Cargando…
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Autores principales: | Yoon, Eileen Laurel, Jun, Dae Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121300/ https://www.ncbi.nlm.nih.gov/pubmed/36916169 http://dx.doi.org/10.3350/cmh.2023.0086 |
Ejemplares similares
-
Waiting for Multi-Stakeholders̕ Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature
por: Yoon, Eileen L., et al.
Publicado: (2022) -
Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023) -
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Yoon, Eileen L., et al.
Publicado: (2023) -
Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
por: Alomari, Mohammad, et al.
Publicado: (2023) -
From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
por: Yeh, Ming-Lun, et al.
Publicado: (2023)